{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Summit Therapeutics Inc. "},"Symbol":{"label":"Symbol","value":"SMMT"},"Address":{"label":"Address","value":"ONE BROADWAY,14TH FLOOR SUITE 106, CAMBRIDGE, Massachusetts, 02142, United States"},"Phone":{"label":"Phone","value":"+1 617 514-7149"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom."},"CompanyUrl":{"label":"Company Url","value":"https://www.smmttx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Mahkam Zanganeh","title":"President, Co-Chief Executive Officer & Director"},{"name":"Manmeet Singh Soni","title":"Director, Chief Financial & Operating Officer"},{"name":"Pawan Parihar","title":"Head-Information Technology"},{"name":"Robert William Duggan","title":"Executive Chairman & Co-Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}